Management Team

​​Peter Moriarty, Co-Founder and Chairman of the Board of Directors, has extensive pharmaceutical industry and entrepreneurial experience. He was a founder of Shire Pharmaceuticals, and worked for Warner-Lambert and Schering-Plough earlier in his career, including management in a number of overseas locations as well as the United States. Additionally, he has founded a number of other companies focused on increasing pharmaceutical sales force productivity and enhancing pharmaceutical companies’ relationships with their physician customers by the appropriate and cost-effective use of remote communication technology. 

Zachary Dutton, C0-Founder, Interim CEO, President and member of the Board of Directors, has more than 15 years of experience in the pharmaceutical industry and in the commercial development of medical foods. His career has included working with Primus Pharmaceuticals, an innovator in the field of medical foods, where his responsibilities included Business Development, Strategic Planning, and Marketing. Earlier in his career, in addition to managing his own consulting firm, he also managed a nutritional company focused on marketing natural products for maintaining mental health. He holds an MBA from the F.W. Olin School of Business at Babson College and a BA in Economics from Queen’s University in Kingston, Ontario, Canada.

Danilo Casadei Massari, Founder, President Europe and Head of Corporate Development, and member of the Board of Directors, has extensive experience as a senior pharmaceutical executive and as an entrepreneur. He was President and CEO of Fidia Pharmaceuticals, USA, and Director of International Corporate Development with Fidia Farmaceutici SpA. As an entrepreneur he has founded several pharmaceutical companies, including most recently, CM&D Pharma Limited, a company focused on prescription Medical Foods, which was acquired by Nestle Health Science in 2011. He is considered an expert in start-ups and co-ventures in the pharmaceutical sector.

Lyle Scritsmier, Chief Financial Officer, has extensive financial and operating management experience in the pharmaceutical services, healthcare, and medical device industries.  He has served as CFO and senior financial executive in a variety of companies ranging from start-ups to publicly traded companies.  He has extensive experience in business development, mergers and acquisitions, strategic alliances, raising venture capital, bank financing, revenue sharing contracts and IPOs.  Former positions include CFO of Pharmaceutical Marketing Services Inc., a publicly traded worldwide provider of sales and marketing services to the pharmaceutical industry; CFO of U.S. Administrators, at that time the nation’s largest third party administrator; and CFO and co-founder of iPhysicianNet.  Most recently, he was CFO and Executive Vice President of MedApps Holding Company, a remote patient monitoring medical device company which was acquired by Alere Inc., a NYSE-traded company.  Mr. Scritsmier earned his CPA designation and was a Senior Audit Manager at KPMG.   Mr. Scritsmier is a graduate of California State University, Pomona (“Cal Poly”) with a Bachelor of Science degree in Accounting and earned an MBA in Finance from the University of Southern California.

Patrick Miller, Ph.D., EVP, Strategic Planning and Analysis, has had considerable experience in the pharmaceutical industry, working with such companies as Merck where he managed Merck’s interest in the joint venture that created the first physician-level Rx database; Andrx where, as Vice President he was responsible for strategic planning and business intelligence, and Wolters Kluwer where his responsibilities included Vice President, Advanced Analytics. Dr. Miller is a graduate of the Wharton School at the University of Pennsylvania, and before commencing his business career, he was a neuroscientist and faculty member at the University of Pennsylvania, where he earned his doctorate as a Fellow at the Institute for Neurological Sciences.

James Attley, Ph.D., VP, Scientific & Clinical Affairs, has extensive Scientific, Marketing, Business Development and Licensing experience in the international pharmaceutical industry. This includes positions as Research and Development Director at Schering-Plough in Japan; International Marketing Director at Schering-Plough’s headquarters in the USA; VP Marketing for Warner Lambert in Japan, and VP, Global Marketing at the company’s headquarters in the USA. Dr. Attley was also Senior Director for Business Development and Licensing for Japan with Schering-Plough, and Senior Director for Corporate Licensing at Merck. He earned his Ph.D. in Neuropharmacology at Liverpool University in the UK where he spent the early part of his career, including positions at Astra Pharmaceuticals and Bristol Myers before relocating to the USA. 


Joseph Sinkule, Pharm.D., VP Clinical Development and Regulatory Affairs, has significant pharmaceutical industry experience with a unique combination of expertise in the area of regulatory affairs, Phase 1-3 clinical trials management, process development, cGMP manufacturing and commercialization aspects of pharmaceuticals.  His experience has included working with Anew Biotechnology, AVI BioPharma, Medelis, Apthera, and Quintiles Transnational, having started his career at the University of Chicago Medical Center where he was an Assistant Professor of Medicine in the Department of Medicine Section of Hematology- Oncology and the Director of Clinical Pharmacology and Pharmacokinetics Program.  Dr. Sinkule was a two-year post-doctoral, Bristol-Myers Oncology fellow at St. Jude Children's Research Hospital in Memphis, TN.